DE69230491D1 - Transformierte zellen zur verhütung oder zur behandlung von virus-induzierten erkrankungen,besonders pathogenen retroviren - Google Patents
Transformierte zellen zur verhütung oder zur behandlung von virus-induzierten erkrankungen,besonders pathogenen retrovirenInfo
- Publication number
- DE69230491D1 DE69230491D1 DE69230491T DE69230491T DE69230491D1 DE 69230491 D1 DE69230491 D1 DE 69230491D1 DE 69230491 T DE69230491 T DE 69230491T DE 69230491 T DE69230491 T DE 69230491T DE 69230491 D1 DE69230491 D1 DE 69230491D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- virus
- retrovirus
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001717 pathogenic effect Effects 0.000 title abstract 3
- 241001430294 unidentified retrovirus Species 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 7
- 241000700605 Viruses Species 0.000 abstract 4
- 239000013543 active substance Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004150 aciclovir Drugs 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000010415 tropism Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9113429 | 1991-10-30 | ||
PCT/FR1992/001017 WO1993008844A1 (fr) | 1991-10-30 | 1992-10-30 | Cellules transformees pour la prevention ou le traitement de maladies induites par des virus, notamment retrovirus pathogenes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69230491D1 true DE69230491D1 (de) | 2000-02-03 |
DE69230491T2 DE69230491T2 (de) | 2000-08-03 |
Family
ID=9418480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69230491T Expired - Fee Related DE69230491T2 (de) | 1991-10-30 | 1992-10-30 | Transformierte zellen zur verhütung oder zur behandlung von virus-induzierten erkrankungen,besonders pathogenen retroviren |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0564645B1 (de) |
JP (1) | JPH06505401A (de) |
AT (1) | ATE188124T1 (de) |
CA (1) | CA2099247A1 (de) |
DE (1) | DE69230491T2 (de) |
ES (1) | ES2142834T3 (de) |
WO (1) | WO1993008844A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6241982B1 (en) | 1988-03-21 | 2001-06-05 | Chiron Corporation | Method for treating brain cancer with a conditionally lethal gene |
US6569679B1 (en) | 1988-03-21 | 2003-05-27 | Chiron Corporation | Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene |
US5662896A (en) | 1988-03-21 | 1997-09-02 | Chiron Viagene, Inc. | Compositions and methods for cancer immunotherapy |
US6133029A (en) | 1988-03-21 | 2000-10-17 | Chiron Corporation | Replication defective viral vectors for infecting human cells |
US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
JPH09503920A (ja) * | 1993-11-18 | 1997-04-22 | チロン ビアジーン,インコーポレイティド | 条件致死遺伝子を利用する組成物及び方法 |
JPH10503641A (ja) * | 1994-05-02 | 1998-04-07 | ユニバーシティ オブ ワシントン | チミジンキナーゼ変異体 |
WO1995030763A2 (en) | 1994-05-09 | 1995-11-16 | Chiron Viagene, Inc. | Retroviral vectors having a reduced recombination rate |
US6013517A (en) | 1994-05-09 | 2000-01-11 | Chiron Corporation | Crossless retroviral vectors |
FR2736931B1 (fr) | 1995-07-17 | 1997-09-19 | Univ Paris Curie | Sequences regulatrices issues du gene cd4 et a expression specifique dans les lymphocytes t matures |
ITTO20100633A1 (it) | 2010-07-21 | 2012-01-21 | Cnh Italia Spa | Meccanismo operativo per un cavo bowden |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4738922A (en) * | 1984-05-25 | 1988-04-19 | Dana Farber Cancer Institute | Trans-acting transcriptional factors |
FR2606030B1 (fr) * | 1986-10-31 | 1989-10-20 | Pasteur Institut | Retrovirus recombinant defectif, son procede de fabrication et ses applications, notamment pour l'etude de l'interaction des retrovirus sauvages avec des lignees cellulaires infectables par celui-ci |
CH684094A5 (de) * | 1988-03-21 | 1994-07-15 | Viagene Inc | Rekombinante Retroviren. |
FR2629469B1 (fr) * | 1988-03-31 | 1990-12-21 | Pasteur Institut | Retrovirus recombinant defectif, son application a l'integration de sequences codantes pour des proteines determinees dans le genome de cultures cellulaires infectables par le retrovirus sauvage correspondant et adns recombinants pour la production de ce retrovirus recombinant |
WO1990011359A1 (en) * | 1989-03-20 | 1990-10-04 | Whitehead Institute For Biomedical Research | Intracellular method of inhibiting hiv in mammalian cells |
WO1990012087A1 (en) * | 1989-04-05 | 1990-10-18 | Novacell Corporation | Infectious targetted replication-defective virion |
FR2651005B1 (fr) * | 1989-08-17 | 1992-01-03 | Pasteur Institut | Lignees de cellules infectables par un retrovirus et contenant un marqueur activable a l'occasion de l'infection |
GB8919607D0 (en) * | 1989-08-30 | 1989-10-11 | Wellcome Found | Novel entities for cancer therapy |
GB9104165D0 (en) * | 1991-02-27 | 1991-04-17 | Wellcome Found | Novel entities for hiv therapy |
-
1992
- 1992-10-30 WO PCT/FR1992/001017 patent/WO1993008844A1/fr active IP Right Grant
- 1992-10-30 EP EP92924753A patent/EP0564645B1/de not_active Expired - Lifetime
- 1992-10-30 ES ES92924753T patent/ES2142834T3/es not_active Expired - Lifetime
- 1992-10-30 DE DE69230491T patent/DE69230491T2/de not_active Expired - Fee Related
- 1992-10-30 CA CA002099247A patent/CA2099247A1/fr not_active Abandoned
- 1992-10-30 JP JP5508209A patent/JPH06505401A/ja active Pending
- 1992-10-30 AT AT92924753T patent/ATE188124T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH06505401A (ja) | 1994-06-23 |
DE69230491T2 (de) | 2000-08-03 |
EP0564645B1 (de) | 1999-12-29 |
ATE188124T1 (de) | 2000-01-15 |
CA2099247A1 (fr) | 1993-05-01 |
EP0564645A1 (de) | 1993-10-13 |
WO1993008844A1 (fr) | 1993-05-13 |
ES2142834T3 (es) | 2000-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY138860A (en) | Hiv protease inhibitors. | |
EA199901031A1 (ru) | Производные бензимидазола | |
ATE199718T1 (de) | Benzothepines mit wirkung als inhibitoren des gallensäuretransports und der taurocholate- aufnahme | |
DE69230491T2 (de) | Transformierte zellen zur verhütung oder zur behandlung von virus-induzierten erkrankungen,besonders pathogenen retroviren | |
ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
ES2182915T3 (es) | Procedimiento de purificacion del factor viii | |
ATE116637T1 (de) | Sulfonische stilbenderivate zur behandlung von viruserkrankungen. | |
DE60136381D1 (de) | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität | |
ATE85523T1 (de) | Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
FR2388828A1 (fr) | 5-iodo-5'-amino-2',5'-didesoxycytidine et medicament contenant cette substance ou un sel de celle-ci | |
IL82523A (en) | Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus | |
FR2388562A1 (fr) | Medicament contenant de la 5'-amino-5'-desoxythymidine ou un sel de cette substance | |
DK0653939T3 (da) | Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner | |
JPS56156211A (en) | Preparation of stable allantoin pharmaceutical | |
RU95109909A (ru) | Способ ингибирования ретровирусной инфекции, ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора | |
FI881123A (fi) | Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar. | |
DE69126977D1 (de) | Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier | |
ES2169033T3 (es) | Empleo de la manganeso-superoxidodismutasa (mn-sod) para la elaboracion de medicamentos para el tratamiento de enfermedades, en una dosis pequeña. | |
ATE137968T1 (de) | Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen | |
EP0247873A3 (de) | Bacteriocine und Zubereitungen derselben für die antivirale Behandlung | |
ATE189604T1 (de) | Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen | |
DE69434019D1 (de) | Zusammensetzung von transdominanten varianten von virus- proteinen zur antiviralen wirkung | |
RU92009797A (ru) | Дезинфицирующий водный раствор для стоматологических оттисков | |
MY101495A (en) | Treatment of diseases caused by viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |